Opioid Prescribing and STOP Act CME – Chapel Hill (May 19, 2018)

May 19, 2018 | 2:00 PM – 3:30 PM

Rizzo Center, Room Magnolia C
150 Dubose Home Lane | Chapel Hill, NC 27517

CME Details

Presented by the North Carolina Medical Society and the Durham-Orange County Medical Society

Cost: Free

Speaker: Christopher Grubb, MD, ABPM

The treatment of pain can be a rewarding part of a medical practice, but the prescribing of opioids is fraught with numerous challenges and pitfalls. Every healthcare provider in our state is obligated to treat pain, and opioid medications are certainly useful in the treatment of moderate and severe pain. However, this mandate must be balanced by the duty to protect patients and the community at large from opiate overdoses, addiction, and the diversion of opioid medications for illicit use. The purpose of this educational program is to improve healthcare providers’ understanding of opioids in the management of pain, including the inherent risks of abuse and misuse, and to impart the new prescribing requirements under the STOP (Strengthen Opioid Misuse Prevention) Act signed into law in 2017.

AMA PRA Category 1 Credit™ – 1.5 hours

Credit Statement:  The Southern Regional AHEC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation: This activity has been planned and implemented in accordance with the Essentials and Standards of the North Carolina Medical Society through the joint providership of the Southern Regional AHEC and the NCMS.  The Southern Regional AHEC is accredited by the NCMS to provide continuing medical education for physicians.

Disclosure Statement:  The Southern Regional AHEC adheres to ACCME Essential Areas and Policies regarding industry support of continuing medical education. Disclosure of faculty/planning committee members and commercial relationships will be made known at the activity. Speakers are also expected to openly disclose a discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

More details and register…


More Future Events


Share this Post